img

Global Neurological Disorder Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Neurological Disorder Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Several government initiatives across various countries to educate masses about the rise of various diseases and increasing healthcare sector producing new drugs are the prime reasons for growth of neurological disorder drugs market. European Parkinson’s Disease Association, in Europe is actively supporting research and development by campaigning to raise awareness, and providing medication to patients is boosting the overall neurological disorder drugs market. This region is also witnessing rising focus on research and development programs that will help in producing affordable and effective drugs. The countries are collectively spending on developing neurological disorder drugs thus, improving the revenue of the market during the forecast period.
Neurological Disorder Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Neurological Disorder Drugs market is projected to reach US$ 24800 million in 2034, increasing from US$ 19270 million in 2022, with the CAGR of 3.6% during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
Staggering increase in brain altering disorders such as Alzheimer’s, epilepsy, Parkinson’s, cerebrovascular, and sclerosis are promoting the pharmaceutical firms to tap into the significantly growing neurological disorder drugs market. This will potentially supplement the market growth in the coming years. Rise of several innovative drugs to manage these diseases will swell up the investments in the market. Increasing number of clinical trials are another reason boosting the market. Rise in geriatric population along with patients with strokes, migraines, and headaches leading to cerebrovascular diseases are likely to augment the growth of the market.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neurological Disorder Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Novartis
GlaxoSmithKline
Merck & Co.
Bayer
AstraZeneca
Boehringer Ingelheim
Teva Pharmaceutical
Segment by Type
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others

Segment by Application


Hospital
Clinic
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Neurological Disorder Drugs market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Neurological Disorder Drugs introduction, etc. Neurological Disorder Drugs Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Neurological Disorder Drugs market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Neurological Disorder Drugs
1.1 Neurological Disorder Drugs Market Overview
1.1.1 Neurological Disorder Drugs Product Scope
1.1.2 Neurological Disorder Drugs Market Status and Outlook
1.2 Global Neurological Disorder Drugs Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Neurological Disorder Drugs Market Size by Region (2024-2034)
1.4 Global Neurological Disorder Drugs Historic Market Size by Region (2024-2024)
1.5 Global Neurological Disorder Drugs Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Neurological Disorder Drugs Market Size (2024-2034)
1.6.1 North America Neurological Disorder Drugs Market Size (2024-2034)
1.6.2 Europe Neurological Disorder Drugs Market Size (2024-2034)
1.6.3 Asia-Pacific Neurological Disorder Drugs Market Size (2024-2034)
1.6.4 Latin America Neurological Disorder Drugs Market Size (2024-2034)
1.6.5 Middle East & Africa Neurological Disorder Drugs Market Size (2024-2034)
2 Neurological Disorder Drugs Market by Type
2.1 Introduction
2.1.1 Antipsychotic
2.1.2 Hypnotic & Sedative
2.1.3 Analgesics
2.1.4 Anticoagulants
2.1.5 Others
2.2 Global Neurological Disorder Drugs Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Neurological Disorder Drugs Historic Market Size by Type (2024-2024)
2.2.2 Global Neurological Disorder Drugs Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Neurological Disorder Drugs Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Neurological Disorder Drugs Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Neurological Disorder Drugs Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Neurological Disorder Drugs Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Neurological Disorder Drugs Revenue Breakdown by Type (2024-2034)
3 Neurological Disorder Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.2 Global Neurological Disorder Drugs Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Neurological Disorder Drugs Historic Market Size by Application (2024-2024)
3.2.2 Global Neurological Disorder Drugs Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Neurological Disorder Drugs Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Neurological Disorder Drugs Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Neurological Disorder Drugs Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Neurological Disorder Drugs Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Neurological Disorder Drugs Revenue Breakdown by Application (2024-2034)
4 Neurological Disorder Drugs Competition Analysis by Players
4.1 Global Neurological Disorder Drugs Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2022)
4.3 Date of Key Players Enter into Neurological Disorder Drugs Market
4.4 Global Top Players Neurological Disorder Drugs Headquarters and Area Served
4.5 Key Players Neurological Disorder Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Neurological Disorder Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Neurological Disorder Drugs Products, Services and Solutions
5.1.4 Novartis Neurological Disorder Drugs Revenue (US$ Million) & (2024-2024)
5.1.5 Novartis Recent Developments
5.2 GlaxoSmithKline
5.2.1 GlaxoSmithKline Profile
5.2.2 GlaxoSmithKline Main Business
5.2.3 GlaxoSmithKline Neurological Disorder Drugs Products, Services and Solutions
5.2.4 GlaxoSmithKline Neurological Disorder Drugs Revenue (US$ Million) & (2024-2024)
5.2.5 GlaxoSmithKline Recent Developments
5.3 Merck & Co.
5.3.1 Merck & Co. Profile
5.3.2 Merck & Co. Main Business
5.3.3 Merck & Co. Neurological Disorder Drugs Products, Services and Solutions
5.3.4 Merck & Co. Neurological Disorder Drugs Revenue (US$ Million) & (2024-2024)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer Neurological Disorder Drugs Products, Services and Solutions
5.4.4 Bayer Neurological Disorder Drugs Revenue (US$ Million) & (2024-2024)
5.4.5 Bayer Recent Developments
5.5 AstraZeneca
5.5.1 AstraZeneca Profile
5.5.2 AstraZeneca Main Business
5.5.3 AstraZeneca Neurological Disorder Drugs Products, Services and Solutions
5.5.4 AstraZeneca Neurological Disorder Drugs Revenue (US$ Million) & (2024-2024)
5.5.5 AstraZeneca Recent Developments
5.6 Boehringer Ingelheim
5.6.1 Boehringer Ingelheim Profile
5.6.2 Boehringer Ingelheim Main Business
5.6.3 Boehringer Ingelheim Neurological Disorder Drugs Products, Services and Solutions
5.6.4 Boehringer Ingelheim Neurological Disorder Drugs Revenue (US$ Million) & (2024-2024)
5.6.5 Boehringer Ingelheim Recent Developments
5.7 Teva Pharmaceutical
5.7.1 Teva Pharmaceutical Profile
5.7.2 Teva Pharmaceutical Main Business
5.7.3 Teva Pharmaceutical Neurological Disorder Drugs Products, Services and Solutions
5.7.4 Teva Pharmaceutical Neurological Disorder Drugs Revenue (US$ Million) & (2024-2024)
5.7.5 Teva Pharmaceutical Recent Developments
6 North America
6.1 North America Neurological Disorder Drugs Market Size by Country (2024-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Neurological Disorder Drugs Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Neurological Disorder Drugs Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Neurological Disorder Drugs Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Neurological Disorder Drugs Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Neurological Disorder Drugs Market Dynamics
11.1 Neurological Disorder Drugs Industry Trends
11.2 Neurological Disorder Drugs Market Drivers
11.3 Neurological Disorder Drugs Market Challenges
11.4 Neurological Disorder Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Neurological Disorder Drugs Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Neurological Disorder Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Neurological Disorder Drugs Market Size Share by Region (2024-2024)
Table 4. Global Neurological Disorder Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Neurological Disorder Drugs Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Neurological Disorder Drugs Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Neurological Disorder Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Neurological Disorder Drugs Revenue Market Share by Type (2024-2024)
Table 9. Global Neurological Disorder Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Neurological Disorder Drugs Revenue Market Share by Type (2024-2034)
Table 11. North America Neurological Disorder Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Neurological Disorder Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Neurological Disorder Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Neurological Disorder Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Neurological Disorder Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Neurological Disorder Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Neurological Disorder Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Neurological Disorder Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Neurological Disorder Drugs Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Neurological Disorder Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Neurological Disorder Drugs Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Neurological Disorder Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Neurological Disorder Drugs Revenue Market Share by Application (2024-2024)
Table 24. Global Neurological Disorder Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Neurological Disorder Drugs Revenue Market Share by Application (2024-2034)
Table 26. North America Neurological Disorder Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Neurological Disorder Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Neurological Disorder Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Neurological Disorder Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Neurological Disorder Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Neurological Disorder Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Neurological Disorder Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Neurological Disorder Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Neurological Disorder Drugs Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Neurological Disorder Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Neurological Disorder Drugs Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Neurological Disorder Drugs Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2022)
Table 39. Date of Key Players Enter into Neurological Disorder Drugs Market
Table 40. Global Neurological Disorder Drugs Key Players Headquarters and Area Served
Table 41. Neurological Disorder Drugs Product Solution and Service
Table 42. Global Neurological Disorder Drugs Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Novartis Basic Information List
Table 45. Novartis Description and Business Overview
Table 46. Novartis Neurological Disorder Drugs Products, Services and Solutions
Table 47. Revenue (US$ Million) in Neurological Disorder Drugs Business of Novartis (2024-2024)
Table 48. Novartis Recent Developments
Table 49. GlaxoSmithKline Basic Information List
Table 50. GlaxoSmithKline Description and Business Overview
Table 51. GlaxoSmithKline Neurological Disorder Drugs Products, Services and Solutions
Table 52. Revenue (US$ Million) in Neurological Disorder Drugs Business of GlaxoSmithKline (2024-2024)
Table 53. GlaxoSmithKline Recent Developments
Table 54. Merck & Co. Basic Information List
Table 55. Merck & Co. Description and Business Overview
Table 56. Merck & Co. Neurological Disorder Drugs Products, Services and Solutions
Table 57. Revenue (US$ Million) in Neurological Disorder Drugs Business of Merck & Co. (2024-2024)
Table 58. Merck & Co. Recent Developments
Table 59. Bayer Basic Information List
Table 60. Bayer Description and Business Overview
Table 61. Bayer Neurological Disorder Drugs Products, Services and Solutions
Table 62. Revenue (US$ Million) in Neurological Disorder Drugs Business of Bayer (2024-2024)
Table 63. Bayer Recent Developments
Table 64. AstraZeneca Basic Information List
Table 65. AstraZeneca Description and Business Overview
Table 66. AstraZeneca Neurological Disorder Drugs Products, Services and Solutions
Table 67. Revenue (US$ Million) in Neurological Disorder Drugs Business of AstraZeneca (2024-2024)
Table 68. AstraZeneca Recent Developments
Table 69. Boehringer Ingelheim Basic Information List
Table 70. Boehringer Ingelheim Description and Business Overview
Table 71. Boehringer Ingelheim Neurological Disorder Drugs Products, Services and Solutions
Table 72. Revenue (US$ Million) in Neurological Disorder Drugs Business of Boehringer Ingelheim (2024-2024)
Table 73. Boehringer Ingelheim Recent Developments
Table 74. Teva Pharmaceutical Basic Information List
Table 75. Teva Pharmaceutical Description and Business Overview
Table 76. Teva Pharmaceutical Neurological Disorder Drugs Products, Services and Solutions
Table 77. Revenue (US$ Million) in Neurological Disorder Drugs Business of Teva Pharmaceutical (2024-2024)
Table 78. Teva Pharmaceutical Recent Developments
Table 79. North America Neurological Disorder Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 80. North America Neurological Disorder Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 81. Europe Neurological Disorder Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 82. Europe Neurological Disorder Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 83. Asia-Pacific Neurological Disorder Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 84. Asia-Pacific Neurological Disorder Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 85. Asia-Pacific Neurological Disorder Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 86. Asia-Pacific Neurological Disorder Drugs Market Share by Region (2024-2024)
Table 87. Asia-Pacific Neurological Disorder Drugs Market Share by Region (2024-2034)
Table 88. Latin America Neurological Disorder Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 89. Latin America Neurological Disorder Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 90. Latin America Neurological Disorder Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 91. Middle East & Africa Neurological Disorder Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 92. Middle East & Africa Neurological Disorder Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 93. Middle East & Africa Neurological Disorder Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 94. Neurological Disorder Drugs Market Trends
Table 95. Neurological Disorder Drugs Market Drivers
Table 96. Neurological Disorder Drugs Market Challenges
Table 97. Neurological Disorder Drugs Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurological Disorder Drugs Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Neurological Disorder Drugs Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Neurological Disorder Drugs Market Share by Regions: 2022 VS 2034
Figure 4. Global Neurological Disorder Drugs Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Neurological Disorder Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Neurological Disorder Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Neurological Disorder Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Neurological Disorder Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Neurological Disorder Drugs Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Antipsychotic
Figure 11. Global Antipsychotic Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Hypnotic & Sedative
Figure 13. Global Hypnotic & Sedative Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Analgesics
Figure 15. Global Analgesics Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Anticoagulants
Figure 17. Global Anticoagulants Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Product Picture of Others
Figure 19. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 20. Global Neurological Disorder Drugs Market Size Share by Type: 2022 & 2034
Figure 21. North America Neurological Disorder Drugs Revenue Market Share by Type (2024-2034)
Figure 22. Europe Neurological Disorder Drugs Revenue Market Share by Type (2024-2034)
Figure 23. Asia-Pacific Neurological Disorder Drugs Revenue Market Share by Type (2024-2034)
Figure 24. Latin America Neurological Disorder Drugs Revenue Market Share by Type (2024-2034)
Figure 25. Middle East and Africa Neurological Disorder Drugs Revenue Market Share by Type (2024-2034)
Figure 26. Hospital Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 27. Clinic Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 28. Global Neurological Disorder Drugs Market Size Share by Application: 2022 & 2034
Figure 29. North America Neurological Disorder Drugs Revenue Market Share by Application (2024-2034)
Figure 30. Europe Neurological Disorder Drugs Revenue Market Share by Application (2024-2034)
Figure 31. Asia-Pacific Neurological Disorder Drugs Revenue Market Share by Application (2024-2034)
Figure 32. Latin America Neurological Disorder Drugs Revenue Market Share by Application (2024-2034)
Figure 33. Middle East and Africa Neurological Disorder Drugs Revenue Market Share by Application (2024-2034)
Figure 34. Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 35. Global Top 5 and Top 10 Players Neurological Disorder Drugs Market Share in 2022
Figure 36. North America Neurological Disorder Drugs Market Share by Country (2024-2034)
Figure 37. U.S. Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 38. Canada Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 39. Germany Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 40. France Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 41. U.K. Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 42. Italy Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 43. Russia Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 44. Nordic Countries Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 45. Asia-Pacific Neurological Disorder Drugs Market Share by Region (2024-2034)
Figure 46. China Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 47. Japan Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 48. South Korea Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 49. Southeast Asia Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 50. India Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 51. Australia Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 52. Latin America Neurological Disorder Drugs Market Share by Country (2024-2034)
Figure 53. Mexico Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 54. Brazil Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 55. Middle East & Africa Neurological Disorder Drugs Market Share by Country (2024-2034)
Figure 56. Turkey Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 57. Saudi Arabia Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 58. UAE Neurological Disorder Drugs Market Size (2024-2034) & (US$ Million)
Figure 59. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries